AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Intrapleural Alteplase-Tyloxapol vs Intrapleural Alteplase-DNase in Pleural Infection

Recruitingn/aAges 18 Years - anyAllNational University of Malaysia
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Pneumonia, thought to be the chief aetiological process in the development of pleural space infection, is defined as an infection of the lung parenchyma with an estimated annual incidence rate of 5-11 cases per 1000 population, with around 50,000 hospital admissions in the U.K. per year. Parapneumonic effusions caused by an infection of the pleural membranes occur in 40-57% of cases of pneumonia. A variable percentage (10-20%) of parapneumonic effusions progresses to empyema (pus) and/or abscess formation (encapsulation). Pleural infection is associated with significant morbidity and mortality, which may be as high as 20-35% in immunocompromised patients. Standard treatment of these collections in adults involves antibiotic therapy, adequate drainage of infected fluid, and surgical intervention if conservative management fails. Appropriate treatment is adequate drainage via an intercost

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: Inclusion Criteria 1. Adult patient aged โ‰ฅ 18 years old 2. Patients with pleural infection (complex parapneumonic effusion or empyema) with poor pleural fluid drainage of โ‰ค 150 ml after 24 hours of chest drain insertion received either t-PA-DNAse or t-PA/Tyloxapol. 3. Clinical features consistent with pleural infection; fulfilling โ‰ฅ 2 of the following characteristics: i) Clinical evidence of infection, such as fever and or elevated C-reactive protein (CRP) or total white blood count (TWBC) ii) Complex pleural effusion proven by thoracic ultrasound is defined as the presence of fibrin strands or septations within the pleural cavity iii) Pleural fluid that fulfils at least one of the characteristics: * Frank Pus, * Exudative type of pleural effusion (according to light's criteria) * Gram stain or culture positive * Lactate dehydrogenase (LDH) \> 900U/L * Acidic with pH \< 7.2 * Glucose level \< 3.3 mmol/L Exclusion Criteria: 1. Incomplete data. 2. Medical records that cannot be retrieved.
๐Ÿ’Š

What it tests

  • Intrapleural t-PA/Dnase arm
  • t-PA (Alteplase) 5-10mg and Tyloxapol 200mg
๐Ÿ“

Where

1 site
National University of Malaysia, Faculty of Medicine
Cheras, Malaysia
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy